Korean Diabetes J.
2008 Jun;32(3):292-292. 10.4093/kdj.2008.32.3.292.
The Biochemical Markers of Coronary Heart Disease Correlates Better to Metabolic Syndrome Defined by WHO than by NCEP-ATP III or IDF in Korean Type 2 Diabetic Patients
- Affiliations
-
- 1Division of Endocrinology, Department of Internal Medicine, Konyang University, Korea.
- KMID: 2298101
- DOI: http://doi.org/10.4093/kdj.2008.32.3.292
Abstract
- No abstract available.
MeSH Terms
Reference
-
1. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002. 287:2570–5281.2. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998. 97:1837–1847.
Article
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Biochemical Markers of Coronary Heart Disease Correlates Better to Metabolic Syndrome Defined by WHO than by NCEP-ATP III or IDF in Korean Type 2 Diabetic Patients
- The Biochemical Markers of Coronary Heart Disease Correlates Better to Metabolic Syndrome Defined by WHO than by NCEP-ATP III or IDF in Korean Type 2 Diabetic Patients
- The Diagnostic Criteria of Metabolic Syndrome and the Risk of Coronary Heart Disease according to Definitions in Men
- Association between Insulin Resistance and Metabolic Syndrome in Healthy Adults: Comparison of the NCEP-ATP III and New IDF Definition
- Metabolic Syndrome Defined by International Diabetes Federation (IDF) or National Cholesterol Education Program (NCEP) and Insulin Resistance
